Biosensors for Medical Wearables to explore key drivers and innovations
SAE Media Group has announced the second Annual Biosensors for Medical Wearables Conference, taking place on the 24th and 25th of October 2022, in Boston, MA, USA.
This year’s event will be exploring the key drivers and innovations of the wearable medical biosensors landscape with insights into the latest technologies uncovering the therapeutic scope of medical biosensors and the potential of wearable sensors for decentralised diagnostic testing.
Interested parties can register for the conference at http://www.biosensors-medical-wear.com
SAE Media Group has published an overview of the speakers and themes that will be covered during the two days, see below an excerpt:
Day 1 - 24 October 2022 - Themes Covered:
Advances in therapeutic scope for medical biosensors
Presentation on: Monitoring a post-surgical episode of care using wearable technologies
- Developing a multi-sensor array to characterise the range of motion across a joint
- Incorporating patient-centric features to increase the probability of success of an intervention
- Creating a holistic solution to bridge the gap between patients and providers
- Analysing episode of care data to solve challenges within in the musculoskeletal space
Led by: Richard Bolander, senior wearable design engineer, TracPatch Health
Decentralised diagnostic monitoring
Presentation on: Assessing Accuracy, Reliability and Usability of In-Ear Vital Signs Monitoring
- An introduction to the current landscape of vital signs monitoring
- Verifying biosensor features and applicability for continuous monitoring of vital signs
- Human factors considerations for in-ear wearable device design
- Components of remote patient monitoring systems for detection, analysis, and transmission of raw data
Led by: Johannes Kreuzer, CEO, Cosinuss
Day 2 - 25 October 2022 - Themes Covered:
Overcoming unmet needs for wearable biosensor devices
Presentation on: What is Electromagnetic Compatibility and Why do Regulators Want Your Biosensors to Comply?
- Disasters caused by electromagnetic disturbances
- What is 60601-1-2 and what do all the terms mean?
- Why regulators still ask for testing on electronics while relaxing requirements on software
Led by: Samir Shah, director, AstraZeneca
Managing digital outcomes and sensors coupled with AI
Presentation on: What’s new in wearable biosensors and AI/ML-based remote patient management?
- How artificial intelligence (AI)/machine learning (ML) coupled with biosensors can improve drug safety and efficacy
- How Chugai and Biofourmis are leveraging wearables and AI/ML to identify objective measures of pain in clinical studies
- Ten years after the first patient was treated with CAR-T therapy: Sensors and predictive analytics monitor patients’ post-treatment to prevent life-threatening issues
- Future clinical and therapeutic potential of AI/ML coupled with biosensors
Led by: Jaydev Thakkar, COO, Biofourmis
View the programme and speaker line – up at http://www.biosensors-medical-wear.com